skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines zolbetuximabQuestion & answer

zolbetuximab · Medicine question

What is the estimated mean elimination half-life of zolbetuximab?

iatroX medicinesPublished 8 November 2026

The answer

Answer

The estimated mean elimination half-life of zolbetuximab is 43.6 days.

Sources for this answer

Vyloy powder for concentrate for solution for infusionAstellas Pharma Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 7Document updated 7 September 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about zolbetuximab

What is the shelf life of unopened Vyloy (zolbetuximab) vials?Can zolbetuximab (Vyloy) affect the ability to drive or use machines?How does zolbetuximab destroy CLDN18.2-positive cells?How is zolbetuximab (Vyloy) administered, and what is the minimum infusion time?How much polysorbate 80 is present in the 100 mg and 300 mg vials of zolbetuximab (Vyloy)?How should unopened Vyloy (zolbetuximab) vials be stored?

zolbetuximab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the zolbetuximab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX